These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25538578)

  • 1. Virtual multiple errands test (VMET): a virtual reality-based tool to detect early executive functions deficit in Parkinson's disease.
    Cipresso P; Albani G; Serino S; Pedroli E; Pallavicini F; Mauro A; Riva G
    Front Behav Neurosci; 2014; 8():405. PubMed ID: 25538578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecological validity of virtual reality daily living activities screening for early dementia: longitudinal study.
    Tarnanas I; Schlee W; Tsolaki M; Müri R; Mosimann U; Nef T
    JMIR Serious Games; 2013 Aug; 1(1):e1. PubMed ID: 25658491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Virtual MET as an assessment tool for executive functions.
    Rand D; Basha-Abu Rukan S; Weiss PL; Katz N
    Neuropsychol Rehabil; 2009 Aug; 19(4):583-602. PubMed ID: 19058093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a Neuro Virtual Reality-based version of the Multiple Errands Test for the assessment of executive functions.
    Raspelli S; Pallavicini F; Carelli L; Morganti F; Poletti B; Corra B; Silani V; Riva G
    Stud Health Technol Inform; 2011; 167():92-7. PubMed ID: 21685648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
    Cammisuli DM; Sportiello MT
    Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring executive dysfunction in Parkinson's disease: Reliability and validity of the Spanish version of Frontal Assessment Battery (FAB-E).
    Hurtado-Pomares M; Terol-Cantero MC; Sánchez-Pérez A; Leiva-Santana C; Peral-Gómez P; Valera-Gran D; Navarrete-Muñoz EM
    PLoS One; 2018; 13(11):e0207698. PubMed ID: 30452476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Computational Approach for the Assessment of Executive Functions in Patients with Obsessive-Compulsive Disorder.
    Pedroli E; La Paglia F; Cipresso P; La Cascia C; Riva G; La Barbera D
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31739514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Virtual Cooking Task: A Preliminary Comparison Between Neuropsychological and Ecological Virtual Reality Tests to Assess Executive Functions Alterations in Patients Affected by Alcohol Use Disorder.
    Chicchi Giglioli IA; Pérez Gálvez B; Gil Granados A; Alcañiz Raya M
    Cyberpsychol Behav Soc Netw; 2021 Oct; 24(10):673-682. PubMed ID: 33761276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual Multiple Errands Test: reliability, usability and possible applications.
    Pedroli E; Cipresso P; Serino S; Pallavicini F; Albani G; Riva G
    Stud Health Technol Inform; 2013; 191():38-42. PubMed ID: 23792839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Instrument Combines Cognitive and Social Functioning Items for Detecting Mild Cognitive Impairment and Dementia in Parkinson's Disease.
    Yu YW; Tan CH; Su HC; Chien CY; Sung PS; Lin TY; Lee TL; Yu RL
    Front Aging Neurosci; 2022; 14():913958. PubMed ID: 35783135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment.
    Samat NA; Abdul Murad NA; Mohamad K; Abdul Razak MR; Mohamed Ibrahim N
    Front Neurosci; 2017; 11():712. PubMed ID: 29326545
    [No Abstract]   [Full Text] [Related]  

  • 13. The Multiple Object Test as a Performance Based Tool to Assess Cognitive Driven Activity of Daily Living Function in Parkinson's Disease.
    Glonnegger H; Beyle A; Cerff B; Gräber S; Csoti I; Berg D; Liepelt-Scarfone I
    J Alzheimers Dis; 2016 Jul; 53(4):1475-84. PubMed ID: 27392856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fist-Edge-Palm (FEP) test has a high sensitivity in differentiating dementia from normal cognition in Parkinson's disease.
    Liu Y; Qiu MY; Zhang YL; Zhang XJ; Truong D; Tan EK; Wu YC
    J Neurol Sci; 2021 Oct; 429():118060. PubMed ID: 34479167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apathy in individuals with Parkinson's disease associated with mild cognitive impairment. A neuropsychological investigation.
    Costa A; Peppe A; Zabberoni S; Scalici F; Caltagirone C; Carlesimo GA
    Neuropsychologia; 2018 Sep; 118(Pt B):4-11. PubMed ID: 29787739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual Reality Functional Capacity Assessment Tool (VRFCAT-SL) in Parkinson's Disease.
    Turner TH; Atkins A; Keefe RSE
    J Parkinsons Dis; 2021; 11(4):1917-1925. PubMed ID: 34334421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication Management Performance in Parkinson's Disease: Examination of Process Errors.
    Sumida CA; Lopez FV; Van Etten EJ; Whiteley N; Moore RC; Litvan I; Lessig S; Gilbert PE; Schmitter-Edgecombe M; Filoteo JV; Schiehser DM
    Arch Clin Neuropsychol; 2021 Oct; 36(7):1307-1315. PubMed ID: 33621315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance.
    Burdick DJ; Cholerton B; Watson GS; Siderowf A; Trojanowski JQ; Weintraub D; Ritz B; Rhodes SL; Rausch R; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Srivatsal S; Edwards KL; Montine TJ; Zabetian CP; Leverenz JB
    Mov Disord; 2014 Sep; 29(10):1258-64. PubMed ID: 25073717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.